BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37565253)

  • 1. Methyl donor supplementation reduces phospho-Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy.
    van Hummel A; Taleski G; Sontag JM; Feiten AF; Ke YD; Ittner LM; Sontag E
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12931. PubMed ID: 37565253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A.
    Ma D; Luo Y; Huang R; Zhao Z; Wang Q; Li L; Zhang L
    Curr Alzheimer Res; 2019; 16(14):1316-1331. PubMed ID: 31902362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization.
    Shirafuji N; Hamano T; Yen SH; Kanaan NM; Yoshida H; Hayashi K; Ikawa M; Yamamura O; Kuriyama M; Nakamoto Y
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.
    Bottiglieri T; Arning E; Wasek B; Nunbhakdi-Craig V; Sontag JM; Sontag E
    J Neurosci; 2012 Jul; 32(27):9173-81. PubMed ID: 22764226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy.
    Tang SJ; Fesharaki-Zadeh A; Takahashi H; Nies SH; Smith LM; Luo A; Chyung A; Chiasseu M; Strittmatter SM
    Acta Neuropathol Commun; 2020 Jul; 8(1):96. PubMed ID: 32611392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B(alpha) subunit expression that correlate with enhanced tau phosphorylation.
    Sontag JM; Nunbhakdi-Craig V; Montgomery L; Arning E; Bottiglieri T; Sontag E
    J Neurosci; 2008 Nov; 28(45):11477-87. PubMed ID: 18987184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.
    Bhaskar K; Hobbs GA; Yen SH; Lee G
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):462-77. PubMed ID: 20609109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new paradigm for regulation of protein phosphatase 2A function via Src and Fyn kinase-mediated tyrosine phosphorylation.
    Sontag JM; Schuhmacher D; Taleski G; Jordan A; Khan S; Hoffman A; Gomez RJ; Mazalouskas MD; Hanks SK; Spiller BW; Sontag E; Wadzinski BE
    J Biol Chem; 2022 Aug; 298(8):102248. PubMed ID: 35820485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
    Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
    J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic Acid Reduces Tau Phosphorylation by Regulating PP2A Methylation in Streptozotocin-Induced Diabetic Mice.
    Zheng M; Zou C; Li M; Huang G; Gao Y; Liu H
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Adenosylmethionine Rescues Cognitive Deficits in the rTg4510 Animal Model by Stabilizing Protein Phosphatase 2A and Reducing Phosphorylated Tau.
    Beauchamp LC; Liu XM; Sedjahtera A; Bogeski M; Vella LJ; Bush AI; Adlard PA; Barnham KJ
    J Alzheimers Dis; 2020; 77(4):1705-1715. PubMed ID: 32925070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative Tauopathies.
    McKenzie-Nickson S; Chan J; Perez K; Hung LW; Cheng L; Sedjahtera A; Gunawan L; Adlard PA; Hayne DJ; McInnes LE; Donnelly PS; Finkelstein DI; Hill AF; Barnham KJ
    ACS Chem Neurosci; 2018 Nov; 9(11):2731-2740. PubMed ID: 29920069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
    Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
    J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbances in PP2A methylation and one-carbon metabolism compromise Fyn distribution, neuritogenesis, and APP regulation.
    Taleski G; Schuhmacher D; Su H; Sontag JM; Sontag E
    J Biol Chem; 2021; 296():100237. PubMed ID: 33380425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The behavioural phenotype of 14-month-old female TAU58/2 transgenic mice.
    Kreilaus F; Masanetz R; Watt G; Przybyla M; Ittner A; Ittner L; Karl T
    Behav Brain Res; 2021 Jan; 397():112943. PubMed ID: 33017638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
    Giacomini C; Koo CY; Yankova N; Tavares IA; Wray S; Noble W; Hanger DP; Morris JDH
    Acta Neuropathol Commun; 2018 May; 6(1):37. PubMed ID: 29730992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy.
    Di Meco A; Li JG; Barrero C; Merali S; Praticò D
    Mol Psychiatry; 2019 Nov; 24(11):1696-1706. PubMed ID: 29728702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr
    Sartori M; Mendes T; Desai S; Lasorsa A; Herledan A; Malmanche N; Mäkinen P; Marttinen M; Malki I; Chapuis J; Flaig A; Vreulx AC; Ciancia M; Amouyel P; Leroux F; Déprez B; Cantrelle FX; Maréchal D; Pradier L; Hiltunen M; Landrieu I; Kilinc D; Herault Y; Laporte J; Lambert JC
    Acta Neuropathol; 2019 Oct; 138(4):631-652. PubMed ID: 31065832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.